Can Sitagliptin reduce hospitalizations for diabetes-related complications, and what are its effects on long-term patient outcomes?
Sunil JoshiExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Sitagliptin has not been conclusively shown to reduce hospitalizations for diabetes-related complications. Its long-term effects primarily include improved glycemic control and potential enhancement of beta-cell function.